Navigation Links
Aamir Rules Out Apologising For Remarks On Narmada Issue

Bollywood actor Aamir Khan, whose latest flick 'Fanaa' could not be released in Gujarat following sharp reaction to his stand on Narmada dam oustees, today ruled out apologising for his remarks even if it hampers his career in the industry.//

Addressing the media at his Bandra residence, the actor said there was no question of tendering apology to anyone. After all, he had said what the Supreme Court had earlier stated in its order, Khan asserted.

Asked whether his stand on the issue could hamper his career, he said "Maybe it will. Perhaps producers will be apprehensive of signing me on." "I welcome the Supreme Court stand on the release of Fanaa, asking the authorities to provide security to theatres wanting to screen the film. It is now upto the BJP Youth Wing workers to decide whether or not they want to respect the Supreme Court, freedom of speech and democracy," Khan said.

"I would only like to appeal to the people of Gujarat not to be fooled by all the propaganda against me. They only have to look me in the eyes to realise the kind of love I have in my heart for Gujarat and its people." Khan seemed disappointed at the kind of support he had received from the industry. "It is upto the film industry to decide what it's future course of action is. The whole nation is watching to see whether it takes a concrete step, or whether it takes a weak step or nothing at all," he added.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Chennai Students Protest Against Aamir Khan for Endorsing Coke
2. Key step forward on International Health Rules
3. U.S. To Tighten Sick Passenger, Quarantine Rules
4. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
5. FDA to Revise Herpes Test Rules in the US
6. Aussie Rules, High on Football Injuries
7. Lady Patient Died after Hospital Turned Inhospitable, Rules Sheriff
8. WHO Rules Out Human Transmission Of Bird Flu In 4 Cases
9. NICE Setback Rules for Pfizers Inhaled Insulin
10. Japanese Court Rules In Patients Favour Over Hepatitis C Scandal
11. British Court Rules In Favour of Free Treatment For Prisoners With HIV
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of a ... Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South Africa. By ... to a patient’s remote health progress, empowering the patient to take direct responsibility for ...
(Date:4/26/2017)... ... ... RawTrition now brings you BioEnergy which is a powder capsule whole food ... RawTrition is taking nutrients to the next level! The superfoods in RawTrition's BioEnergy ... (unlike the synthetically made options that are on the market). , Founder of RawTrition, ...
(Date:4/25/2017)... ... 2017 , ... Bellus Medical, a leader in medical aesthetics, ... class of photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically ... aging, and minimize the appearance of pores – all with minimal downtime and ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... and HR decision-makers are preparing for how his administration could impact the employee ... insight into what changes are most likely to make it through Congress. His ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
Breaking Medicine Technology: